What the Research Is Telling Us Two studies from 2024 have raised big red flags: A study published in JAMA Ophthalmology found that semaglutide users were over four times more likely to develop NAION than those on other diabetes drugs
Whether you're on Semaglutide Injection, Tirzepatide Injection, or any compounded formulation, the monthly cost stays flat regardless of dose escalation
Antibody Fab fragments are useful tools for structural characterization of target proteins and were used recently to obtain the first crystal structure of the glucagon receptor ECD and a new crystal structure of the glucose-dependent insulinotropic polypeptide (GIP) receptor ECD 28,29
More serious risks, though rare, include accidental injection into a blood vessel, which may cause skin damage, severe pain, or vision changesseek immediate medical attention if these occur
In fact, high-profile examples of payers pulling back on coverage are stacking up: North Carolinas state health plan dropped GLP-1s after spending $100 million, Ascension eliminated all weight-loss drug coverage, and Mayo Clinic capped lifetime GLP-1 benefits at $20,000
Key Takeaway: If you don't see results, the problem is often absorption